Maxim Group Weighs in on NexGel’s Q3 Earnings (NASDAQ:NXGL)

NexGel, Inc. (NASDAQ:NXGL) – Research analysts at Maxim Group issued their Q3 2026 earnings per share estimates for NexGel in a research note issued to investors on Tuesday, September 29th. Maxim Group analyst N. Rahman expects that the company will post earnings per share of ($0.24) for the quarter. Maxim Group has a “Hold” rating on the stock. The consensus estimate for NexGel’s current full-year earnings is ($0.94) per share. Maxim Group also issued estimates for NexGel’s Q4 2026 earnings at ($0.20) EPS, FY2026 earnings at ($0.94) EPS and FY2027 earnings at ($0.22) EPS.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of NexGel in a research report on Monday, July 13th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Reduce” and a consensus target price of $2.00.

NexGel Trading Down 2.3%

Shares of NXGL opened at $0.17 on Monday. NexGel has a 12 month low of $0.16 and a 12 month high of $2.89. The stock’s 50-day moving average is $0.33 and its two-hundred day moving average is $0.49. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.43 and a quick ratio of 0.27. The stock has a market cap of $1.66 million, a PE ratio of -0.24 and a beta of 0.82.

NexGel (NASDAQ:NXGL) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.28). NexGel had a negative return on equity of 121.18% and a negative net margin of 51.26%.The business had revenue of $3.69 million for the quarter, compared to analyst estimates of $4.32 million.

Hedge Funds Weigh In On NexGel

An institutional investor recently bought a new stake in NexGel stock. Board of Trustees of The Leland Stanford Junior University bought a new position in shares of NexGel, Inc. (NASDAQ:NXGL) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 32,500 shares of the company’s stock, valued at approximately $52,000. NexGel accounts for approximately 0.0% of Board of Trustees of The Leland Stanford Junior University’s investment portfolio, making the stock its 19th largest holding. Board of Trustees of The Leland Stanford Junior University owned 0.40% of NexGel as of its most recent SEC filing. 2.21% of the stock is owned by institutional investors and hedge funds.

About NexGel

NexGel, Inc develops and manufactures high-water-content, electron-beam-crosslinked aqueous polymer hydrogels. Its products are designed to provide electrical conductivity, moisture retention, cushioning, and cooling for a range of medical, consumer, and industrial applications.

The company’s hydrogel products are used in medical electrodes for applications such as electrocardiography, neuromuscular stimulation, and defibrillation, as well as in ultrasound procedures. NexGel also supplies nonconductive hydrogels for wound care, burn care, scar treatment, and cosmetic products, along with specialized formulations for veterinary and other commercial uses.

Based in Langhorne, Pennsylvania, NexGel serves customers through business-to-business relationships with medical-device manufacturers and other product companies.